Clinical Practice Guideline for Prostate Cancer Treatment.
Full version
Map
Help
Back - CPG Versions
Download
Prostate Cancer CPG
(5.5 MB)
Table of Contents
Drop down all menus
Roll up all menus
Presentation
Authors and collaborators
Questions to be answered
Summary of recommendations
Introduction
Scope and objectives
Methodology
Classification of prostate cancer
4.1. TNM Classification
4.2. Histopathological grade
4.3. Classification according to the clinical or pathological stage
4.4. Classification depending on the risk
Localised prostate cancer
5.1. Prognosis factors
5.2. Initial choice of treatment
5.3. Surgery
5.4. Radiotherapy
5.5. Hormone therapy
5.6. Monitoring
Locally advanced prostate cancer
6.1. Initial choice of treatment
6.2. Adjuvant radiotherapy
6.3. Lymphadenectomy
6.4. Adjuvant/neoadjuvant hormone therapy
Prostate cancer in PSA relapse
7.1. Definition of PSA relapse
7.2. Salvage treatment after surgery
7.3. Salvage treatment after radiotherapy
7.4. When to start hormone therapy
7.5. Intermittent vs continuous hormone therapy
Disseminated prostate cancer
8.1. Hormone therapy
8.2. Chemotherapy
8.3. Bisphosphonates and radiopharmaceuticals
Dissemination and implementation
Recommendations for future research
Appendices
Bibliography
Full list of tables and figures
Copyright